# Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

> **NCT01701752** · PHASE1 · COMPLETED · sponsor: **Immune Targeting Systems Ltd** · enrollment: 120 (actual)

## Conditions studied

- Influenza A

## Interventions

- **BIOLOGICAL:** FP-01.1 + Placebo
- **BIOLOGICAL:** FP-01.1 + TIV
- **BIOLOGICAL:** FP-01.1-Adjuvant + Placebo
- **BIOLOGICAL:** FP-01.1-Adjuvant + TIV
- **BIOLOGICAL:** Adjuvant + TIV
- **BIOLOGICAL:** Placebo + TIV
- **BIOLOGICAL:** FP-01.1
- **BIOLOGICAL:** FP-01.1-Adjuvant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01701752
- **Lead sponsor:** Immune Targeting Systems Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01701752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01701752, "Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01701752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*